Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to see if adding Mindfulness training to diabetes education reduces feelings of stress and makes it easier to adhere to healthy behaviors that improve diabetes outcomes (such as hemoglobin A1c).
Background: One million Veterans (25%) who receive health care through Veterans Health Administration (VHA) have diabetes and are therefore responsible for daily diabetes self-management (DSM). DSM is essential for glycemic control and prevention of potentially life threatening and disabling complications such as severe hypoglycemia, kidney failure, acute coronary syndrome and stroke. Importantly, 40% of individuals with diabetes suffer from diabetes-related distress (DRD) that interferes with their ability to sustain healthy self-management behaviors, and may be particularly problematic for Veterans who are at higher risk for comorbid negative emotional states such as depression and post-traumatic stress disorder.
Diabetes self-management education (DSME) has traditionally contained little content or skill-building directly related to stress management, leaving this critical component of diabetes self-management largely unaddressed in DSME. In the investigators' pilot work, the investigators have developed a brief stress management intervention known as Mind-STRIDE, which contains mindfulness training and home practice and is easily integrated into existing DSME. While the investigators have previously demonstrated the feasibility, patient acceptability, and initial efficacy of Mind-STRIDE, its effects on diabetes-related psychological and physiological patient outcomes remain unknown. There is, therefore, a critical need to determine the efficacy of this targeted mindfulness intervention for improving DRD, diabetes self-efficacy, DSM behaviors, and metabolic control of Veterans with diabetes in order to offer comprehensive, evidence-based DSME that improves Veteran-centric diabetes outcomes.
Objectives: The objectives of this study are to determine the efficacy of Mind-STRIDE for improving DRD, diabetes self-efficacy, DSM, and metabolic control, and to characterize distinctive Veteran experiences with DRD and Mind-STRIDE.
Methods: To achieve these objectives, the investigators will conduct a randomized controlled trial of 126 Veterans at a large VA medical center in southwest PA. Participants will be assigned to one of two study conditions: an experimental group that receives routine diabetes education plus Mind-STRIDE, or to a usual care group that receives diabetes education alone. DRD, diabetes self-efficacy, and DSM will be assessed using self-report questionnaires. Metabolic control (Hemoglobin A1c) will be assessed using standard laboratory procedures. Data will be collected at baseline, 12-weeks, and 24-weeks, and will be analyzed using mixed-effects models. Telephone interviews will be conducted at 15-weeks post-intervention in a subset of participants from the experimental group, and will be analyzed using modified Grounded Theory methods. Quantitative and qualitative findings will be compared and interpreted using Convergent Parallel Design.
Status: Assessments were completed 4/09/2020.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diabetes Self Management Education (DSME) + Mind-STRIDE | Experimental | Will receive routine diabetes self-management education + the Mind-STRIDE intervention |
|
| DSME alone | No Intervention | Usual care control |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mind-STRIDE | Behavioral | Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education |
|
| Measure | Description | Time Frame |
|---|---|---|
| Problem Areas in Diabetes Scale (PAID) -(Measures Diabetes Distress) | A 20-item psychometrically validated self-report questionnaire on a 5 point Likert scale (0= not problem; 4= a serious problem). The scores are summed and multiplied by 1.25. Minimum value = 0; Maximum value = 100. Higher scores denote higher levels of diabetes related distress. The cutoff for significant distress is 33; a score of 40 is consistent with diabetes burn-out. | baseline, 12 weeks and 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Diabetes Self-efficacy Scale (DSES) | An 8-item psychometrically validated self-report questionnaire on a 10- point Likert Scale (1= Not confident at all; 10 = Totally confident). This scale measures diabetes self efficacy, a critical pathway to improved self-management that refers to an individual's confidence in their ability to perform key diabetes self-management behaviors. Scores are derived as the mean of the 8 questions. Minimum score =1; Maximum Score = 10. Higher scores denote higher diabetes self-efficacy. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in 6-item PROMIS Short Form v1.0 Pain Interference 6 b | A psychometrically validated 7-item instrument on a 5 point Likert scale (1= "not at all"- 5 and "very much") determining the degree to which pain has interfered with aspects of daily living during the past 7 days. It is a general and not disease-specific measure of pain. Scores are summed (Min. value = 6; Max value =35). Total raw scores are then converted into a T-score for each participant. The T-scores rescales the raw score into a standardized score with a mean of 50 and a standard deviation of 10. A score of 50 is the average for the United States general population with a standard deviation of 10. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Monica M. DiNardo, PhD ARNP CDE | VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Pittsburgh | Pennsylvania | 15240 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35346971 | Derived | DiNardo MM, Greco C, Phares AD, Beyer NM, Youk AO, Obrosky DS, Morone NE, Owen JE, Saba SK, Suss SJ, Siminerio L. Effects of an integrated mindfulness intervention for veterans with diabetes distress: a randomized controlled trial. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002631. doi: 10.1136/bmjdrc-2021-002631. |
Not provided
Not provided
There are currently no plans to share Individual Participant Data (IPD).
Not provided
Not provided
Not provided
Not provided
One participant was excluded because of concomitant enrollment in a similar study that could have confounded results.
Dates of recruitment: 11-1-2016 to 10-31-2019 Diabetes outpatient clinic at VA Pittsburgh Healthcare System, Oakland campus
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Diabetes Self Management Education (DSME) + Mind-STRIDE | Will receive routine diabetes self-management education + the Mind-STRIDE intervention Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education |
| FG001 | DSME Alone | Usual care control |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Diabetes Self Management Education (DSME) + Mind-STRIDE | Will receive routine diabetes self-management education + the Mind-STRIDE intervention Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education |
| BG001 |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Problem Areas in Diabetes Scale (PAID) -(Measures Diabetes Distress) | A 20-item psychometrically validated self-report questionnaire on a 5 point Likert scale (0= not problem; 4= a serious problem). The scores are summed and multiplied by 1.25. Minimum value = 0; Maximum value = 100. Higher scores denote higher levels of diabetes related distress. The cutoff for significant distress is 33; a score of 40 is consistent with diabetes burn-out. | Numbers analyzed differ among rows from the overall number analyzed because of attrition and missed visits. | Posted | Mean | Standard Deviation | units on a scale | baseline, 12 weeks and 24 weeks |
|
6 months
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Diabetes Self Management Education (DSME) + Mind-STRIDE | Will receive routine diabetes self-management education + the Mind-STRIDE intervention Mind-STRIDE: Mindful Stress Reduction in Diabetes Education- mindfulness training with home practice will be introduced as part of diabetes education |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Monica DiNardo PhD, Primary Investigator | VAPHS, Center for Heath Equity Research and Promotion | 412 360-2262 | monica.dinardo@va.gov |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jun 2, 2015 | Mar 9, 2021 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline, 12 weeks and 24 weeks |
| Hemoglobin A1c (A1C) | A blood test that measures the percentage of glycated hemoglobin in red blood cells as a means of estimating the average blood sugar concentrations for the preceding two to three months. Lower percentage denote better blood glucose levels and may range from 4.5% in persons without diabetes t0 >15% in persons with poorly managed hyperglycemia. . An A1C <7% has been associated with prevention of diabetes complications. A1C>9% denotes chronic,severe blood glucose elevation. All tests were performed at VAPHS according to National Glyco-hemoglobin Standardization Program-approved methods. | baseline, 12 weeks and 24 weeks |
| Mindfulness Attention and Awareness Scale (MAAS) | A 15-item psychometrically validated questionnaire on a 6-point Likert scale (1=Almost Always and 6= Never) The scale is scored by computing the mean of the 15 items. (Minimum score = 1; maximum score = 6). Higher scores reflect higher levels of dispositional (trait) mindfulness. Average score in the general US population is 4.22. Mindfulness is a mental state achieved by focusing one's awareness on the present moment, while calmly acknowledging and accepting one's feelings, thoughts, and bodily sensations. | baseline, 12 weeks and 24 weeks |
| Body Weight | Weight in pounds | baseline, 12 weeks and 24 weeks |
| Blood Pressure | Change in mean arterial blood pressure, calculated as blood pressure + 2 (diastolic blood pressure) divided by 3. | baseline, 12 weeks and 24 weeks |
| Patient Health Questionnaire (PHQ8) | The Patient Health Questionnaire (PHQ-8) is a standardized, validated scale that assesses 8 key symptoms of depression experienced over the prior two weeks on a 4-point Likert scale (0=not at all; 3= nearly every day). It is the same as the PHQ-9, without the question regarding suicidal ideation. Score is the sum of the 8 items (Minimum value =0; Maximum= 24). A score of 10 or greater is considered major depression, 20 or more is severe major depression. | baseline, 12 weeks and 24 weeks |
| PTSD Checklist- Civilian Version (PCL-C) | The Abbreviated PCL-C is a validated 6-item civilian version of the PTSD check- list designed for use in general medical settings to assess symptoms of PTSD using a 5-point Likert scale. Scores reflect how much the participant has been bothered by specific PTSD symptoms during the past month. (0= "not at all; 4= "extremely") .Scores are summed. (Minimum value =0; maximum values = 24). Scores >14 are suggestive of PTSD, with higher scores reflecting greater PTSD symptoms. | baseline, 12 weeks and 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA), General Diet | A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of general dietary behaviors each day over the past 7-days and number of days per week over the past month (0= no days; 7 = 7 days). Scores = mean number of days per week ( Minimum score =0; maximum score = 7) . Higher scores denote healthier dietary behaviors. | baseline, 12 weeks and 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA), Specific Diet | A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of eating fruits and vegetables and high fat foods each day over the past 7-days. Minimum maximum values = (0= no days; 7 = 7 days). 1 item is scored as mean number of days (Minimum score =0; maximum score = 7), while the 2nd item is summed and reversed (0= 7days; 7= 0 days). The scores for the two items are summed for the subscale score (Minimum score=0; maximum score =7) Higher scores denote healthier dietary behaviors. Each subscale of the SDSCA is scored separately, without a calculated composite score. | baseline, 12 weeks and 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA) Space Carbohydrates | One item from the SDSCA that assesses the number of days over the past 7-days in which the participant spaced carbohydrates evenly throughout the day. Minimum score 0; maximum score 7. Higher scores denote healthier dietary behaviors. | baseline, 12 weeks and 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA)- Exercise | A 2-item subscale of the SDSCA that measures the number of days over the past 7-days on which the participant engaged in physical activity . Score = mean score of days over the past 7 days (Min.=1; Max.=7). Higher scores denote healthier exercise behaviors. Each SDSCA subscale scored separately. | baseline, 12 weeks, 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA)- - Footcare | A 2-item subscale of the SDSCA that measures the number of days the participant 1) inspected their feet and 2) inspected the inside of their shoes over the past 7-days. Score = mean number of days (Min=0; max=7). Higher scores denote healthier footcare behaviors. | baseline, 12 weeks, 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA)- Blood Glucose Testing | A 2-item subscale of the SDSCA that measures 1) the number of days on which the participant tested their blood glucose over the past 7 days and 2) the number of days on which they tested their blood glucose according to the number of times recommended by their health care provider over the past 7-days. Scores= mean number of days per week. Minimum score is 0 Maximum score is 7.Higher scores denote healthier self-monitoring behaviors. Each SDSCA subscale scored separately | baseline, 12 weeks, 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA)- - Smoking | A 2-item subscale of the SDSCA that measures 1) whether the participant smoked even a puff of a cigarette in the past 7 days (0=no; 1= yes) and 2) if so, the number of cigarettes smoked on an average day. The scores are summed. Minimum score =0, maximum score = >40. Lower scores denote healthier smoking behaviors. | baseline,12 weeks, 24 weeks |
| Summary of Diabetes Self-Care Activities (SDSCA)- - Medication Adherence | A 2-item subscale of the SDCSA that measures the frequency of 1) taking prescribed insulin and 2)prescribed number of diabetes pills each day over the past 7-days. Scores from the 2 items are summed. Minimum score =0; maximum score = 7). Higher scores denote greater adherence to diabetes medications. Participants entered N/A if they were not prescribed insulin or diabetes pills. Each subscale of the SDSCA is scored independently with no calculated composite score. | baseline, 12 weeks, 24 weeks |
| baseline, 12 weeks and 24 weeks |
| Insomnia Severity Index (ISI) | Seven psychometrically tested items on a 4 point Likert scale that measure difficulty falling asleep and staying asleep (0= none; 4=very severe) and satisfaction with current sleep patterns (0=very satisfied; 4=very dissatisfied), Noticeable impairment of quality of life (0= not noticeable; 4= very much noticeable), Worry/distress re: sleep (0=not at all worried; 4=very much worried); Interference of sleep problem to daily functioning (0=not interfering; 4= very much interfering). Scores are summed. Minimum score = 0; maximum score = 20). Higher scores denote greater insomnia severity. Scores over 14 denote insomnia; Scores 8 to 14 denote subthreshold insomnia. | baseline, 12 weeks and 24 weeks |
| Physician Decision |
|
| DSME Alone |
Usual care control |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Living with partner | Married/living with partner vs living alone | Count of Participants | Participants |
|
| Post-High School Education | Count of Participants | Participants |
|
| Employment Status- working full or part time | Count of Participants | Participants |
|
| Diabetes Phenotype-type 2 diabetes | Count of Participants | Participants |
|
| Charlson Co-Morbidity Index (CMI) | Comorbidity: 21-item Charlson Comorbidity Index (CCI) predicts one-year mortality based on age range (<40=0;>70=4), and comorbid conditions (e.g. diabetes with/without complications; MI, stroke, solid tumor with/ without metastasis). Each condition is assigned a score of 1 to 6 depending on the magnitude of its associated1-yr mortality risk. Scores are summed and range from a minimum Score of 1 (since all participants had diabetes) to a maximum of 37 for highest risk for age and each condition. Higher scores reflect greater risk, with scores ≥5 representing more severe risk. | Mean | Standard Deviation | units on a scale |
|
| Insulin use | Diabetes medications: insulin vs. non-insulin use | Count of Participants | Participants |
|
| Duration of Diabetes | Mean | Standard Deviation | years |
|
| OG001 | DSME Alone | Usual care control |
|
|
|
| Secondary | Diabetes Self-efficacy Scale (DSES) | An 8-item psychometrically validated self-report questionnaire on a 10- point Likert Scale (1= Not confident at all; 10 = Totally confident). This scale measures diabetes self efficacy, a critical pathway to improved self-management that refers to an individual's confidence in their ability to perform key diabetes self-management behaviors. Scores are derived as the mean of the 8 questions. Minimum score =1; Maximum Score = 10. Higher scores denote higher diabetes self-efficacy. | Statistical Test of hypothesis. Differing sample sizes are due to attrition and missed research visits. Analyzed as intention to treat in mixed models with imputation as last value moved forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Hemoglobin A1c (A1C) | A blood test that measures the percentage of glycated hemoglobin in red blood cells as a means of estimating the average blood sugar concentrations for the preceding two to three months. Lower percentage denote better blood glucose levels and may range from 4.5% in persons without diabetes t0 >15% in persons with poorly managed hyperglycemia. . An A1C <7% has been associated with prevention of diabetes complications. A1C>9% denotes chronic,severe blood glucose elevation. All tests were performed at VAPHS according to National Glyco-hemoglobin Standardization Program-approved methods. | Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed research assessment, missed visit or failure to go to the lab to have bloodwork done following the research assessment. Three participant in the intervention group and 2 participants in the DSME-alone group did not have A1C done following the 24 week assessment related to closure of the outpatient lab due to COVID-19. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | percentage of glycated Hemoglobin | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Mindfulness Attention and Awareness Scale (MAAS) | A 15-item psychometrically validated questionnaire on a 6-point Likert scale (1=Almost Always and 6= Never) The scale is scored by computing the mean of the 15 items. (Minimum score = 1; maximum score = 6). Higher scores reflect higher levels of dispositional (trait) mindfulness. Average score in the general US population is 4.22. Mindfulness is a mental state achieved by focusing one's awareness on the present moment, while calmly acknowledging and accepting one's feelings, thoughts, and bodily sensations. | Number analyzed differs in one or more rows from overall number analyzed due to attrition and missed or abbreviated visit. One participant had to leave the 24 week visit after completing just 3 of the questionnaires and before completing the other questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including the primary outcome assessment were completed. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Body Weight | Weight in pounds | Number analyzed differs in one or more rows from overall number analyzed due to attrition or missed visit. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | Pounds | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Blood Pressure | Change in mean arterial blood pressure, calculated as blood pressure + 2 (diastolic blood pressure) divided by 3. | Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visit or shortened visit. Two participants did not have their BP taken at week 24 due to social distancing and COVID-19 precautions. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | mmHg | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Patient Health Questionnaire (PHQ8) | The Patient Health Questionnaire (PHQ-8) is a standardized, validated scale that assesses 8 key symptoms of depression experienced over the prior two weeks on a 4-point Likert scale (0=not at all; 3= nearly every day). It is the same as the PHQ-9, without the question regarding suicidal ideation. Score is the sum of the 8 items (Minimum value =0; Maximum= 24). A score of 10 or greater is considered major depression, 20 or more is severe major depression. | Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visit or missed assessments.One participant had to leave the 24 week visit after completing just 3 of the questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including the primary outcome assessment (PAID) were completed. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | PTSD Checklist- Civilian Version (PCL-C) | The Abbreviated PCL-C is a validated 6-item civilian version of the PTSD check- list designed for use in general medical settings to assess symptoms of PTSD using a 5-point Likert scale. Scores reflect how much the participant has been bothered by specific PTSD symptoms during the past month. (0= "not at all; 4= "extremely") .Scores are summed. (Minimum value =0; maximum values = 24). Scores >14 are suggestive of PTSD, with higher scores reflecting greater PTSD symptoms. | Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed or incomplete assessments. One participant left the 24- week visit early after completing just 3 of the questionnaires. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since 3 assessments including that for the primary outcome assessment were completed. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA), General Diet | A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of general dietary behaviors each day over the past 7-days and number of days per week over the past month (0= no days; 7 = 7 days). Scores = mean number of days per week ( Minimum score =0; maximum score = 7) . Higher scores denote healthier dietary behaviors. | Number analyzed differs in one or more rows from overall number analyzed due to attrition or missed visit. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA), Specific Diet | A 2-item subscale of the psychometrically validated SDSCA that measures the frequency of eating fruits and vegetables and high fat foods each day over the past 7-days. Minimum maximum values = (0= no days; 7 = 7 days). 1 item is scored as mean number of days (Minimum score =0; maximum score = 7), while the 2nd item is summed and reversed (0= 7days; 7= 0 days). The scores for the two items are summed for the subscale score (Minimum score=0; maximum score =7) Higher scores denote healthier dietary behaviors. Each subscale of the SDSCA is scored separately, without a calculated composite score. | Differing sample sizes are due to attrition and missed research visits. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA) Space Carbohydrates | One item from the SDSCA that assesses the number of days over the past 7-days in which the participant spaced carbohydrates evenly throughout the day. Minimum score 0; maximum score 7. Higher scores denote healthier dietary behaviors. | Differing sample sizes are due to attrition and missed research visits. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA)- Exercise | A 2-item subscale of the SDSCA that measures the number of days over the past 7-days on which the participant engaged in physical activity . Score = mean score of days over the past 7 days (Min.=1; Max.=7). Higher scores denote healthier exercise behaviors. Each SDSCA subscale scored separately. | Differing sample sizes are due to attrition and missed research visits. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks, 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA)- - Footcare | A 2-item subscale of the SDSCA that measures the number of days the participant 1) inspected their feet and 2) inspected the inside of their shoes over the past 7-days. Score = mean number of days (Min=0; max=7). Higher scores denote healthier footcare behaviors. | Differing sample sizes are due to attrition and missed research visits. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks, 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA)- Blood Glucose Testing | A 2-item subscale of the SDSCA that measures 1) the number of days on which the participant tested their blood glucose over the past 7 days and 2) the number of days on which they tested their blood glucose according to the number of times recommended by their health care provider over the past 7-days. Scores= mean number of days per week. Minimum score is 0 Maximum score is 7.Higher scores denote healthier self-monitoring behaviors. Each SDSCA subscale scored separately | Differing sample sizes are due to attrition and missed research visits or skipped questionnaires. One person in each group did not complete the questionnaire at baseline because they were not prescribed blood glucose monitoring by their diabetes care providers. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks, 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA)- - Smoking | A 2-item subscale of the SDSCA that measures 1) whether the participant smoked even a puff of a cigarette in the past 7 days (0=no; 1= yes) and 2) if so, the number of cigarettes smoked on an average day. The scores are summed. Minimum score =0, maximum score = >40. Lower scores denote healthier smoking behaviors. | Differing sample sizes are due to attrition and missed research visits or incomplete assessment. Two participants in the DSME + Mind-STRIDE intervention group did not complete the Smoking subset of the SDSCA because they do not smoke. | Posted | Mean | Standard Deviation | score on a scale | baseline,12 weeks, 24 weeks |
|
|
|
|
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA)- - Medication Adherence | A 2-item subscale of the SDCSA that measures the frequency of 1) taking prescribed insulin and 2)prescribed number of diabetes pills each day over the past 7-days. Scores from the 2 items are summed. Minimum score =0; maximum score = 7). Higher scores denote greater adherence to diabetes medications. Participants entered N/A if they were not prescribed insulin or diabetes pills. Each subscale of the SDSCA is scored independently with no calculated composite score. | Differing sample sizes are due to attrition, missed research visits or missing assessment questions. One person in Usual Care Control Group did not take any diabetes medications as reflected in the overall number of participants analyzed in that group. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks, 24 weeks |
|
|
|
|
| Other Pre-specified | Change in 6-item PROMIS Short Form v1.0 Pain Interference 6 b | A psychometrically validated 7-item instrument on a 5 point Likert scale (1= "not at all"- 5 and "very much") determining the degree to which pain has interfered with aspects of daily living during the past 7 days. It is a general and not disease-specific measure of pain. Scores are summed (Min. value = 6; Max value =35). Total raw scores are then converted into a T-score for each participant. The T-scores rescales the raw score into a standardized score with a mean of 50 and a standard deviation of 10. A score of 50 is the average for the United States general population with a standard deviation of 10. | Number analyzed differs in one or more rows from overall number analyzed due to attrition, missed visits, or skipped assessments. One participant had to leave the 24 week before completing the Pain Interference assessment. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis because he completed 3 of the other assessments including the primary outcome assessment.. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| Other Pre-specified | Insomnia Severity Index (ISI) | Seven psychometrically tested items on a 4 point Likert scale that measure difficulty falling asleep and staying asleep (0= none; 4=very severe) and satisfaction with current sleep patterns (0=very satisfied; 4=very dissatisfied), Noticeable impairment of quality of life (0= not noticeable; 4= very much noticeable), Worry/distress re: sleep (0=not at all worried; 4=very much worried); Interference of sleep problem to daily functioning (0=not interfering; 4= very much interfering). Scores are summed. Minimum score = 0; maximum score = 20). Higher scores denote greater insomnia severity. Scores over 14 denote insomnia; Scores 8 to 14 denote subthreshold insomnia. | Number analyzed differs in one or more rows from overall number analyzed due to attrition,missed visits or skipped assessments. One participant had to leave the 24 week visit before completing the ISI. He was then lost to follow-up. He was retained in the Intention-to-Treat analysis since he completed 3 of the other assessments including the primary outcome assessment. Analyzed as intention to treat with imputation moving last value forward. | Posted | Mean | Standard Deviation | score on a scale | baseline, 12 weeks and 24 weeks |
|
|
|
|
| 0 |
| 65 |
| 0 |
| 65 |
| 0 |
| 65 |
| EG001 | DSME Alone | Usual care control | 0 | 67 | 0 | 67 | 0 | 67 |
Not provided
Not provided
Not provided
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 week |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|
| 12 weeks |
|
|
| 24 weeks |
|
|